Colon Cancer Patients With Genetic Abnormality Live Longer
WebMD News Archive
What really has researchers puzzled, however, is why tumors with
microsatellite instability appear to be more aggressive -- larger and
faster-growing -- than other tumors, but actually have a better prognosis.
"This is an enigma," says Henry T. Lynch, MD in an interview with
WebMD. Lynch, a pioneer of cancer genetics studies, first described HNPCC, also
called Lynch syndrome. "Our group did the ... study that confirmed the
better prognosis, better survival in each stage. We have no idea why, with the
ominous pathology that these patients have, they do better." Lynch is
professor of medicine and chairman of the department of preventive medicine at
Creighton University School of Medicine in Omaha, Neb.
He speculates that because the cells are genetically unstable, they may be
more susceptible to normal body processes that are designed to remove old or
damaged cells. Alternatively, some features of cells with microsatellite
instability may make them more vulnerable to the types of drugs used in
chemotherapy for colorectal cancer, Lynch says.
- Colon cancer patients under the age of 51 who have a type of genetic
abnormality in their tumors called microsatellite instability live longer and
are at a lower risk for the disease spreading, according to a new study.
- Microsatellite instability refers to sections of mismatched DNA that fail
to be repaired during cell division.
- Researchers are puzzled as to why tumors with microsatellite instability
signal a better prognosis, even though they are more aggressive than other